The International Journal of Clinical Oncology (IJCO) welcomes original research papers on all aspects of clinical oncology that report the results of novel and timely investigations. Reports on clinical trials are encouraged. Experimental studies will also be accepted if they have obvious relevance to clinical oncology. Membership in the Japan Society of Clinical Oncology is not a prerequisite for submission to the journal. Papers are received on the understanding that: their contents have not been published in whole or in part elsewhere; that they are subject to peer review by at least two referees and the Editors, and to editorial revision of the language and contents; and that the Editors are responsible for their acceptance, rejection, and order of publication.

90% of authors who answered a survey reported that they would definitely publish or probably publish in the journal again

Journal information

Editor-in-Chief
  • Yasumasa Nishimura
Publishing model
Hybrid. Open Access options available

Journal metrics

2.503 (2018)
Impact factor
2.301 (2018)
Five year impact factor
33 days
Submission to first decision
99 days
Submission to acceptance
190,878 (2019)
Downloads

Latest issue

Volume 25

Issue 5, May 2020

Including Invited Reviews on PD-1 blockade cancer immunotherapy

Latest articles

Journal updates

  • COVID-19 and impact on peer review

    As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times.  Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

View all updates

Societies, partners and affiliations

Subscribe

Subscription
$99.00
Note this is only the net price. Taxes will be calculated during checkout.
  • Receive printed journal issues for the subscription year
  • Immediate eJournal access with complete access to all articles
  • Subscription expires 12/31/2020

Advertisement

About this journal

Electronic ISSN
1437-7772
Print ISSN
1341-9625
Abstracted and indexed in
  1. CNKI
  2. Chemical Abstracts Service (CAS)
  3. EBSCO Academic Search
  4. EBSCO Biomedical Reference Collection
  5. EBSCO Discovery Service
  6. EBSCO STM Source
  7. EMBASE
  8. Gale
  9. Gale Academic OneFile
  10. Gale InfoTrac
  11. Google Scholar
  12. INIS Atomindex
  13. Institute of Scientific and Technical Information of China
  14. Japanese Science and Technology Agency (JST)
  15. Journal Citation Reports/Science Edition
  16. Medline
  17. Naver
  18. OCLC WorldCat Discovery Service
  19. ProQuest Biological Science Database
  20. ProQuest Central
  21. ProQuest Health & Medical Collection
  22. ProQuest Health Research Premium Collection
  23. ProQuest Medical Database
  24. ProQuest Natural Science Collection
  25. ProQuest Oncogenes and Growth Factors Abstracts
  26. ProQuest Pharma Collection
  27. ProQuest Public Health Database
  28. ProQuest Research Library
  29. ProQuest SciTech Premium Collection
  30. ProQuest-ExLibris Primo
  31. ProQuest-ExLibris Summon
  32. Reaxys
  33. SCImago
  34. SCOPUS
  35. Science Citation Index Expanded (SciSearch)
  36. Semantic Scholar
Copyright information

Rights and permissions

Springer policies

© Japan Society of Clinical Oncology